2023 DMC and Expo Speakers | Healthcare Distribution Alliance

Speakers

Natalie Adams

Vice President, Strategic Sourcing - National Brands

Cardinal Health, Inc.
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Natalie Adams

Vice President, Strategic Sourcing - National Brands

Cardinal Health, Inc.
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Natalie Adams has built a 23-year career at Cardinal Health in Dublin, Ohio. She currently serves as Vice President, Strategic Sourcing with responsibility for the relationships and contracts with all National Brand Pharmaceutical manufacturers. She has held varying roles across the med and pharma segments with broad experience including sourcing, procurement, IT business transformation leadership, and inventory management.

She is a passionate people leader, focused on driving strong results and developing current and future leaders. She holds a Bachelor of Arts in French Horn Performance from Capital University and an MBA with focus in Organizational Leadership from Franklin University.

Natalie is a mother of two sons, Ben (17) and Oliver (13) and stepmother to her husband Ryan’s daughter Emma (20) and twins, Jack and Ellie (17). She is a fitness enthusiast and music lover, supporting her children in their musical endeavors.
Steven A. Adams

Director, Strategic National Stockpile, Administration for Strategic Preparedness and Response

Centers for Disease Control & Prevention/OPHPR/DSNS
- Update from the Administration for Strategic Preparedness and Response (ASPR)
  Wednesday, March 15, 2023 | 10:15—11:00 AM
  
  JW Grand Ballroom 5 & 6
Steven A. Adams

Director, Strategic National Stockpile, Administration for Strategic Preparedness and Response

Centers for Disease Control & Prevention/OPHPR/DSNS
- Update from the Administration for Strategic Preparedness and Response (ASPR)
  Wednesday, March 15, 2023 | 10:15—11:00 AM
  
  JW Grand Ballroom 5 & 6
Chris J. Anderson

Director, Quality Management

Cardinal Health, Inc.
- E4: Temperature Lane Mapping
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 7 & 8
Chris J. Anderson

Director, Quality Management

Cardinal Health, Inc.
- E4: Temperature Lane Mapping
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 7 & 8
Chris has been with Cardinal Health since 1987 in Quality and Regulatory Affairs, at both the field and corporate levels, responsible for wholesale drug distribution compliance. Over the past ten years, he has built a quality system supporting the Pharmaceutical Distribution business.

Chris led the development of the current innovative and sustainable cold chain packaging process for Cardinal Health that has been recognized through the industry through various awards, speaking invitations and publications.

In his quality role, Chris has regulatory responsibility for the quality systems that support compliance, temperature management and DSCSA regulatory support.

Chris was a member of the United States Pharmacopeia (USP) Packaging and Distribution Expert Committee Member.

He holds a Bachelor of Arts degree from Norwich University in Political Science and a Master of Arts degree in Organizational Behavior.
Christopher Antypas

President & Chief Operating Officer

Asti’s South Hills Pharmacy
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Christopher Antypas

President & Chief Operating Officer

Asti’s South Hills Pharmacy
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Christopher Antypas is currently serving as President at Asti's South Hills Pharmacy, a retail pharmacy that is pushing the boundaries of community pharmacy practice. A native of Pittsburgh, Chris earned his Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy, and has extensive experience in a variety of pharmacy practice settings. In addition to his role at Asti's, he owns and operates 2 additional pharmacies in Pittsburgh, PA that each serve a unique patient population. His pharmacies include a specialty pharmacy that supports patients suffering from complex conditions by providing specialty therapies, as well as a long-term care pharmacy that services patients residing in a facility.

In addition to his experience as a business owner, manager, and clinician, Chris is practicing as a pharmacy consultant and adviser. He is presently the Director of Pharmacy Solutions for Henderson Brothers, Inc., an insurance and benefits brokerage/consulting firm in Pittsburgh. In this role, Chris helps to support large, self-funded employers manage their pharmacy benefit with thoughtful and innovative strategies.

Chris currently serves as a board member of the Pennsylvania Pharmacists Association and also sits on the advisory board for both Value Drug Company and Prescribe Wellness. He has been named as a Luminary for The Community Pharmacy Enhanced Service Network (CPESN) as well as The Pennsylvania Pharmacists Care Network (PPCN), and in this capacity, he is helping to reshape community pharmacy practice with innovation and cutting-edge pharmacy care. Known for his commitment to advance pharmacy practice, Chris has been invited to speak nationally and regionally on a variety of pharmacy topics. Chris was recently honored to be named the 2019 ‘Pharmacist of the Year’ by the Pennsylvania Pharmacists Association, and in October of 2020, Chris was named the 'Next Generation Pharmacist - Entrepreneur of the Year'.

Pharmacy has been a life's passion for Chris, and when he's not solving medication related problems, he enjoys every minute with his wife and 3 children in the South Hills of Pittsburgh.
Maurice Ashley

First African-American Chess Grandmaster, Analyst

Commentator and Emcee
- Decision-Making Perspective: Seeing Challenges from a Different Point of View
  Tuesday, March 14, 2023 | 8:30—9:30 AM
  
  JW Grand Ballroom 5 & 6
Maurice Ashley

First African-American Chess Grandmaster, Analyst

Commentator and Emcee
- Decision-Making Perspective: Seeing Challenges from a Different Point of View
  Tuesday, March 14, 2023 | 8:30—9:30 AM
  
  JW Grand Ballroom 5 & 6
Maurice Ashley made history in 1999 when he became the first African American chess grandmaster. He is a three-time national championship coach, author of Chess for Success: Using an Old Game to Build New Strengths in Children and Teens, ESPN commentator, iPhone app designer, puzzle inventor and motivational speaker.

Maurice is well known for providing dynamic live tournament coverage of world-class chess competitions and matches. His high-energy, unapologetic and irreverent commentary combines Brooklyn street smarts with professional ESPN-style sports analysis. He has covered every class of elite event, including the World Chess Championships, the US Chess Championships, the Grand Chess Tour, and the legendary “man vs. machine” matches between Garry Kasparov and IBM’s Deep Blue.

Traveling the world as an ardent spokesperson for the many character-building effects of chess, Maurice shares how chess principles and strategies can be applied to improve business practices and assist with personal growth. Maurice also acts as a master of ceremonies and inspirational speaker at business conferences and high-class chess events.

Maurice has received multiple community service awards from city governments, universities and community groups for his work. In recognition of his immense contribution to the game, he was inducted into the US Chess Hall of Fame in 2016 and the Brooklyn Technical High School Hall of Fame in 2018.
Michael Benedick

Pharmaceutical ERP Expert

Blue Link ERP
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Michael Benedick

Pharmaceutical ERP Expert

Blue Link ERP
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Josh M. Bolin

Associate Executive Director for Government Affairs and Innovation

National Association of Boards of Pharmacy®
- G4: State Regulator Preparation for DSCSA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 7 & 8
Josh M. Bolin

Associate Executive Director for Government Affairs and Innovation

National Association of Boards of Pharmacy®
- G4: State Regulator Preparation for DSCSA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 7 & 8
Josh Bolin serves as the Associate Executive Director for Federal Affairs and Strategy for the National Association of Boards of Pharmacy (NABP). Since joining NABP in 2005, Josh has worked on development of PMP InterConnect, multiple pharmacy accreditation and inspection programs, including accreditation programs for durable medical equipment and specialty pharmacy, and inspection programs for the prescription drug supply chain, sterile and nonsterile compounding and nuclear pharmacy. Josh also worked with NABP’s member boards of pharmacy to develop NABP’s Universal Inspection form and Multistate Inspection Blueprint, which are tools to assist the boards of pharmacy in conducting uniform inspections of sterile compounding facilities. Josh is currently working with NABP member boards of pharmacy on uniform processes and tools with respect to the DSCSA.
Jon Brown

Manager-Pharmacy Purchasing and Logistics

Indiana University Health
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Jon Brown

Manager-Pharmacy Purchasing and Logistics

Indiana University Health
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Sean Edward Brzozowski

Program Analyst

Healthcare Ready
- F3: Ensuring Supply Chain Resilience When Crisis Is the New Normal
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 3 & 4
Sean Edward Brzozowski

Program Analyst

Healthcare Ready
- F3: Ensuring Supply Chain Resilience When Crisis Is the New Normal
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 3 & 4
Daniel Burke

Special Agent, Manager-Cyber Operations Branch, Office of Criminal Investigations

U.S. Food and Drug Administration
- Cybersecurity Concerns Within the Pharmaceutical Industry
  Wednesday, March 15, 2023 | 9:00—10:15 AM
  
  JW Grand Ballroom 5 & 6
Daniel Burke

Special Agent, Manager-Cyber Operations Branch, Office of Criminal Investigations

U.S. Food and Drug Administration
- Cybersecurity Concerns Within the Pharmaceutical Industry
  Wednesday, March 15, 2023 | 9:00—10:15 AM
  
  JW Grand Ballroom 5 & 6
Special Agent Dan Burke started his federal law enforcement career with the IRS-Criminal Investigation Division in 1995. In 1997, he transferred to the U.S. Customs Service where he primarily investigated on-line child pornography, drug and financial investigations. In 2002, he was promoted to Supervisory Special Agent for U.S. Customs, which is now known as ICE’s-Homeland Security Investigations, where he managed a Financial Investigations Task Force. In 2005, Dan joined FDA’s Office of Criminal Investigations (OCI).

During his career, Dan has completed a number of successful cybercrime investigations spanning the globe and is also part of OCI’s cadre of digital forensics specialists. In 2012, Dan was promoted to Manager of the Cybercrimes Investigation Unit (CcIU) and also began the development of OCI’s international expansion and liaison efforts. In 2019, Dan was promoted to manager of the Cyber Operations Branch and currently oversees OCI’s Digital Forensics, Cybercrime Investigations and Technical Surveillance Units. Dan has attained a variety of certifications in the field of digital and cyber-forensics, is listed on the United Nations Security Council Roster of Experts and has testified before the U.S. Senate on behalf of the FDA. He holds a master's degree in Criminal Justice Administration from the University of Colorado-Denver where he is currently a member of their adjunct faculty.
Ian Cannell

Business Process Consultant / DSCSA National Project Sponsor

Kaiser Permanente
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Ian Cannell

Business Process Consultant / DSCSA National Project Sponsor

Kaiser Permanente
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Robert Celeste

Founder

Center for Supply Chain Studies
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Robert Celeste

Founder

Center for Supply Chain Studies
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Bob Celeste’s deep understanding and knowledge of the healthcare supply chain, including current standards and technologies, along with his ability to harness his expertise and innovate around the complexities of track-and-trace implementation, serialization and regulatory compliance, has made him a trusted industry partner.

Along with his work with both state and federal regulators, Bob often serves as an advisor to the FDA, State Boards of Pharmacy and other governing organizations. Most recently he was tapped as an advisor to the USAID and international regulators on the identification and tracking of drugs and medical supplies.

Bob launched the Center for Supply Chain Studies in 2015 to continue his practice of utilizing strategic simulations to address the challenges and demands of the supply chain. His expertise extends across many industries, including pharmaceutical, consumer goods, fresh foods, aerospace, automotive, specialty chemicals and others.

Prior to founding the Center, Bob was Senior Director at GS1 US, where he worked with industry on standards-based, item-level traceability and was the lead in developing the first DSCSA implementation guideline.
Christopher Clement

AVP, Distribution

Apexus, LLC
- C3: Successful 340B Implementation
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 3 & 4
Christopher Clement

AVP, Distribution

Apexus, LLC
- C3: Successful 340B Implementation
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 3 & 4
Chris Clement has 20 years of experience in 340B, pharmaceutical distribution, and generic Rx strategies. Chris has spent the last 6 years working for the 340B Prime Vendor, Apexus, and is Director of the Prime Vendor Distribution Network consisting of 29 traditional, specialty and medical-surgical distributors. He has been a guest speaker at a number of industry conferences regarding 340B operations and implementation, and has served on the 340B University faculty. Chris is also a 340B Apexus Certified Expert (ACE).

Prior to joining Apexus, Chris built his career through 13 years with AmerisourceBergen as a subject matter expert on the generic pharmaceutical marketplace, as well as a field sales coach, trainer, analyst and key account contact. His diverse background in the wholesaler industry gives him unique insight into the generics marketplace, and in understanding the 340B supply chain.
Jason D. Cochran

President/ Chief Connection Officer, Psychologist

Telos, LLC
- A4: Building Connected Organizations for the Future of Work
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 7 & 8
Jason D. Cochran

President/ Chief Connection Officer, Psychologist

Telos, LLC
- A4: Building Connected Organizations for the Future of Work
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 7 & 8
Moogega Cooper

Planetary Protection Engineer

National Aeronautics and Space Administration (NASA)
- Limitless
  Monday, March 13, 2023 | 8:30—9:30 AM
  
  JW Grand Ballroom 5 & 6
Moogega Cooper

Planetary Protection Engineer

National Aeronautics and Space Administration (NASA)
- Limitless
  Monday, March 13, 2023 | 8:30—9:30 AM
  
  JW Grand Ballroom 5 & 6
Trailblazing Engineer of the famed Mars Rover ‘Perseverance’ Mission for NASA’s Jet Propulsion Laboratory

A real life “Guardian of the Galaxy,” Dr. Moogega “Moo” Cooper holds the awesome responsibility of keeping the red planet safe from any of the Earth’s contaminants. Moo is the planetary protection lead of the famed NASA 2020 Mars mission — with its highly viewed landing on February 18, 2021. Her work with NASA's Jet Propulsion Laboratory (JPL) is integral to the ongoing mission to discern whether Mars could be habitable for humans and that we don’t harm what’s already there — a job she has been working up to for most of her life.

After graduating from high school at 16, Cooper studied physics as an undergraduate, received a master's degree and went on to earn her PhD in mechanical engineering at 24 years old with a dissertation on spacecraft materials.

Moo is passionate about empowering organizations and others to achieve their dreams and overcome obstacles that she articulately conveys through her life story and love of her work. A role model for women in science and technology, she is also passionate about introducing more people to the wonders of the STEAM world, including by talking about her work to boys and girls from underrepresented communities and appearing on shows like Because Space and Bill Nye Saves the World.

Moo is a recipient of several awards, including the NASA Early Career Public Achievement Medal, the Charles Elachi Award for Exceptional Early Career Achievement and JPL Voyager Awards for Technical Leadership.
Kelly Copes-Anderson

Global Head of Diversity, Equity and Inclusion

Lilly USA, LLC
- F4: Introducing Diversity, Equity and Inclusion into Your Workplace
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 7 & 8
Kelly Copes-Anderson

Global Head of Diversity, Equity and Inclusion

Lilly USA, LLC
- F4: Introducing Diversity, Equity and Inclusion into Your Workplace
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 7 & 8
Kelly Copes-Anderson is currently the Global Head of Diversity, Equity & Inclusion (DEI) for Lilly. In this role, Kelly is responsible for advancing and embedding DEI as a strategic approach across the enterprise to maximize business performance and create a competitive advantage for the company.

Kelly has worked at Lilly for 25 years, primarily in the commercial business function, and has held a variety of positions in marketing, market research and manufacturing across the company including recent roles as Global Brand Leader in Breast Cancer, and Sr. Director Oncology Insights and Data Analytics. Kelly has been recognized for her ability to effectively lead diverse global teams, launch new products, deliver innovative solutions to complex challenges, drive change, and consistently exceed business results. She is also known for mentoring and sponsorship of a range of professionals.

Kelly received her BS in Chemical Engineering at Michigan State becoming a first-generation college graduate in her family. She also earned her MBA from Indiana University followed by the recent certification from the Harvard Business Analytics program in September 2020.

Outside of Lilly, Kelly serves as a board member for the Boys and Girls Club of Central Indiana as well as a former board member and long-term supporter of Easter Seals Crossroads. Kelly is married to Arvie Anderson and they have two sons, Brenton and Bryce.
Scott Cornwell

Chief Supply Chain Officer

Dispensary of Hope, LLC
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Scott Cornwell

Chief Supply Chain Officer

Dispensary of Hope, LLC
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Jesse Cortez

Vice President - Diversity, Equity and Inclusion

McKesson Corporation
- F4: Introducing Diversity, Equity and Inclusion into Your Workplace
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 7 & 8
Jesse Cortez

Vice President - Diversity, Equity and Inclusion

McKesson Corporation
- F4: Introducing Diversity, Equity and Inclusion into Your Workplace
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 7 & 8
Larry P. Cote

Chief Compliance Officer

Cote Law PLLC
- F2: Controlled Substances Legal Panel (closed to the media)
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 1 & 2
Larry P. Cote

Chief Compliance Officer

Cote Law PLLC
- F2: Controlled Substances Legal Panel (closed to the media)
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 1 & 2
Larry Cote is one of the nation’s foremost Drug Enforcement Administration (DEA) compliance attorneys. He focuses his practice on counseling clients across the spectrum of regulatory compliance and enforcement issues involving the Controlled Substances Act (CSA). Having spent six and a half years heading up a national law firm’s DEA Compliance and Litigation Practice Group, Larry took the practice to his own firm, Cote Law PLLC, in 2018. Immediately before his law firm tenure, Larry was associate chief counsel for the Diversion and Regulatory Litigation Section at DEA. In this position, he took a prominent role in many of DEA’s most significant enforcement actions and compliance efforts.
Tom Cotter

Executive Director

Healthcare Ready
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
- F3: Ensuring Supply Chain Resilience When Crisis Is the New Normal
Tom Cotter

Executive Director

Healthcare Ready
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
- F3: Ensuring Supply Chain Resilience When Crisis Is the New Normal
Tom Cotter, MPH, serves as executive director of Healthcare Ready, bringing more than a decade of global health readiness and response expertise to expand nonprofit’s mission-driven work addressing health equity. Healthcare Ready is a nonprofit organization established in 2007 to help strengthen the US healthcare system and assist all communities in planning for, responding to, and recovering from disasters and disease pandemics.

Over his 15-year career as a public health and emergency management professional, Cotter has piloted and launched innovative international strategies to localize emergency response operations and build sustainable response functions worldwide. Most recently, Cotter served as the director of emergency response and preparedness for Project HOPE, a renowned global health and humanitarian relief organization. Prior to that role, he developed and managed public health and emergency response programs in several countries for non-profit organizations.

Cotter’s educational background is heavily focused on public health and emergency response. He has a Master of Public Health degree from Boston University School of Public Health and a certificate from Johns Hopkins Bloomberg School of Public Health. Cotter received his Bachelor of Arts in Public and Community Service Studies at Providence College in Rhode Island and attended the University of the Philippines as part of an international research team focused on the socioeconomic determinants of health. Cotter has also served as an emergency response coordinator for the U.S. Department of Health & Human Services since 2013.
Chester "Chip" Davis, Jr.

President and Chief Executive Officer

Healthcare Distribution Alliance
- Welcome Address
  Monday, March 13, 2023 | 8:00—8:20 AM
  
  JW Grand Ballroom 5 & 6
Chester "Chip" Davis, Jr.

President and Chief Executive Officer

Healthcare Distribution Alliance
- Welcome Address
  Monday, March 13, 2023 | 8:00—8:20 AM
  
  JW Grand Ballroom 5 & 6
Chester “Chip” Davis, Jr., JD, is the President and Chief Executive Office of HDA and President of the HDA Research Foundation. HDA is the national association representing pharmaceutical distributors — the vital link between the nation’s 1,400 manufacturers and nearly 330,000 sites of care. Mr. Davis oversees HDA’s day-to-day
operations and is responsible for ensuring that the organization’s members have a strong advocacy voice in legislation, regulation and policy.

Mr. Davis joined HDA in March 2020 from the Association of Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he served as President and Chief Executive Officer since 2015. Prior to AAM, Mr. Davis held leadership roles at the Pharmaceutical Research and Manufacturers of America and AstraZeneca, where in 2007 he was recognized as one of the
inaugural winners of the CEO Leadership Award.

Mr. Davis earned an undergraduate degree in Accounting from the University of Delaware, and a Juris Doctor from the University of Baltimore School of Law.
Jeffery W. Denton

Cencora, Inc.
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Jeffery W. Denton

Cencora, Inc.
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Jeff Denton is currently Senior Director, IT Global Secure Supply Chain at AmerisourceBergen. With over 30 years of experience in the wholesale distribution business, Jeff has held positions of increasing responsibility in finance, procurement, contracts and chargebacks as well as Information Technology.

Over the last 13 years, Jeff has been very involved in a variety of aspects around the supply chain security initiative. In addition, he has participated in numerous standards-activities within HDA and GS1-US/Global.

His current responsibilities include Enterprise IT solutions for AmerisourceBergen’s Global Secure Supply Chain program. Jeff serves at the IT lead and is the key liaison across all of the various business units – aligning implementation with standardization.
Anita T. Ducca

Healthcare Distribution Alliance
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Anita T. Ducca

Healthcare Distribution Alliance
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Anita T. Ducca is HDA’s Senior Vice President of Regulatory Affairs. She serves as the chief liaison and advocate on behalf of HDA with federal regulatory agencies, including FDA and DEA. She has been with the organization since 2002. Prior to joining HDA, Ducca was the Director of Regulatory Affairs for the American Red Cross Biomedical Services (ARC), where she was responsible for internal and external regulatory, compliance and health and safety. Anita also served in a regulatory advocacy capacity for the American Petroleum Institute. Earlier, she has also served on the staff of several federal regulatory agencies, including the Food and Drug Administration, the Office of Management and Budget and the Environmental Protection Agency. Ducca has a BA in Mathematics from Boston College and a MS in Biostatistics from Georgetown University.
Heather Easterling

Senior Managing Consultant, 340B Solutions, Health Systems

McKesson Corporation
- B3: 340B Update
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 3 & 4
Heather Easterling

Senior Managing Consultant, 340B Solutions, Health Systems

McKesson Corporation
- B3: 340B Update
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 3 & 4
Dr. Heather Easterling is a Senior Managing Consultant for 340B Solutions at McKesson. Her primary responsibilities include engaging with health system customers to optimize their 340B program and implementing McKesson 340B strategy.

Prior to McKesson, Dr. Easterling served as the System Administrative Officer of Pharmacy Services at MUSC Health in Charleston, SC, Clinical Associate Dean of Medical Center Affairs for the MUSC College of Pharmacy, and Director of Pharmacy Graduate Education for residency programs.

Dr. Easterling earned her Doctor of Pharmacy from the Medical University of South Carolina College of Pharmacy and a Master’s in Business Administration from The Citadel Graduate College. She also completed a 24-month pharmacy practice management residency.

Dr. Easterling’s main area of experience is in health system pharmacy operations and promoting the profession through expansion of clinical pharmacy services. She has extensive knowledge of the 340B program and using the program’s benefit to promote health care services to the underserved.
Charles H. Forsaith

Vice President, PCSC

Healthcare Distribution Alliance
- A3: Pharmaceutical Cargo Security Coalition Activity Update
- Cybersecurity Concerns Within the Pharmaceutical Industry
Charles H. Forsaith

Vice President, PCSC

Healthcare Distribution Alliance
- A3: Pharmaceutical Cargo Security Coalition Activity Update
- Cybersecurity Concerns Within the Pharmaceutical Industry
Chuck Forsaith is the Vice President of the Healthcare Distribution Alliance’s Pharmaceutical Cargo Security Coalition (PCSC), which offers supply chain security intelligence; access to contacts from industry, government, and vendor trade disciplines; as well as education opportunities to its membership. The Coalition, which Forsaith formed in 2006, brings together professionals from a wide variety of disciplines, to monitor the security of pharmaceutical goods in transit and storage, all over the world. The PCSC became part of HDA in 2017.
Forsaith has been involved in pharmaceutical supply chain security for more than 20 years, following a career as both a New Hampshire municipal and State Police officer. He also, directed security operations for a United States military intelligence gathering installation.

He has lectured both domestically and internationally in the disciplines of supply chain and site security for such organizations as the Department of Justice, the Federal Bureau of Investigation, the U.S. Food and Drug
Administration, the Drug Enforcement Administration, the Department of Homeland Security, the Central Intelligence Agency, United States Customs, the United States Merchant Marine Academy, the Partnership for Safe Medicines, ASIS and TAPA. He is an active member of the American Society of Industrial Security, the Transported Asset Protection Association, the Overseas Security Advisory Council and the National Association of Drug Diversion Investigators.

Forsaith has either authored articles for, or been featured in articles published in The New York Times, The Wall Street Journal, the UK's London Times, Germany's Frankfurter Allgemeine Zeitung, the Financial Times, Business Week, American Shipper, Security Info Watch, Life Science Reader, Security Technology Executive, Cargo Security International and Homeland Security Today.
Kristen L. Freitas

SVP, Federal Government Affairs and Alliance Development

Healthcare Distribution Alliance
- B2: State of the Union: 2023 Federal Policy Outlook
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 1 & 2
Kristen L. Freitas

SVP, Federal Government Affairs and Alliance Development

Healthcare Distribution Alliance
- B2: State of the Union: 2023 Federal Policy Outlook
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 1 & 2
Kristen L. Freitas is HDA’s SVP, Federal Government Affairs and Alliance Development. She is responsible for federal legislative advocacy where she develops and maintains relationships with key congressional legislators and their staff, as well as conducts direct lobbying in support of association policies and positions. Kristen also is responsible for fostering relationships with supply chain stakeholders to develop alliances supporting safe and reliable healthcare distribution in the U.S. Further, Kristen oversees the HDA Political Action Committee (PAC) and grassroots activities.

Prior to joining HDA, Freitas worked as Manager, Government Affairs for PacifiCare Health Systems, and before that, for a specialty nursing association and for the National Association for Chain Drug Stores (NACDS). Prior to NACDS, she served as a Director of Outreach for a former Member of Congress.

She holds a degree in International Relations from Michigan State University and a Master of Public Administration (MPA) from George Mason University.
Elizabeth A. Gallenagh

General Counsel and Senior Vice President, Supply Chain Integrity

Healthcare Distribution Alliance
- A2: ESG in the Healthcare Distribution Industry
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Elizabeth A. Gallenagh

General Counsel and Senior Vice President, Supply Chain Integrity

Healthcare Distribution Alliance
- A2: ESG in the Healthcare Distribution Industry
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Elizabeth A. Gallenagh is the General Counsel and Senior Vice President, Supply Chain Integrity at the Healthcare Distribution Alliance (HDA). She is the organization’s chief legal officer, overseeing all legal matters for HDA. Gallenagh also serves as HDA’s primary expert on prescription drug traceability, supply chain safety and integrity, distributor licensure and tax issues.

Since joining HDA, Ms. Gallenagh led the Alliance's industry-wide efforts to replace a 50-state patchwork of pedigree laws with one national traceability solution, which became a reality through the enactment of the Drug Supply Chain Security Act (DSCSA) in November 2014. In 2014, she was honored by the industry with the Distribution Management Award for Industry Leadership, which honors an individual who has exhibited the highest standards of honesty and integrity, working to enhance industry relations and knowledge, as well as supply chain efficiency and security.

Gallenagh is a graduate of the George Mason University School of Law and The George Washington University.
John A. Gilbert

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel (closed to the media)
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 1 & 2
John A. Gilbert

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel (closed to the media)
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 1 & 2
John Gilbert is a Director with the law firm of Hyman, Phelps & McNamara, P.C. The firm advises and represents a broad range of clients on legal issues concerning food, drug, medical devices, biologicals, pharmacy and cosmetic law and regulation.

Mr. Gilbert advises clients extensively on legal and regulatory issues concerning controlled substances, prescription drugs and precursor chemicals. His expertise extends to all regulatory and enforcement areas on federal and state laws and regulations governing the scheduling, manufacturing, distribution, dispensing, import and export of drugs and chemicals. He has extensive knowledge of the relationship and interaction of the federal Controlled Substances Act (CSA) and state laws governing controlled substances and precursor chemicals.
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

Cencora, Inc.
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

Cencora, Inc.
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Gregg is currently Vice President – Manufacturer Operations & Data Services and Secure Supply Chain Lead for Cencora (formerly AmerisourceBergen). The SSC project team is delivering the Track & Trace and serialization requirements of the DSCSA. Gregg’s focus is currently on Manufacturer & Customer onboarding activities as well as DC activation for inbound scanning at receiving, returns, and exception handling while also sending outbound EPCIS messages to downstream trading partners.

Prior to AB, Gregg was the US Serialisation Lead at GSK leading the work on the DSCSA saleable returns project and developing GSK’s long-term solution for the DSCSA requirements in 2023. At GSK, Gregg held positions ranging from Analytics Reporting Manager in R&D Clinical Operations, Data Lead for the US SAP implementation, and Director of Data Quality in the Transparency Data Operations & Reporting team in Pharma Finance. Prior to GSK, Gregg worked for 6 years at Pfizer in Global Logistics & Supply in the Enterprise Data Management group focused on SAP Material Master.

Gregg has almost 25 years of experience in multiple Leadership & Senior Data roles in both the Pharmaceutical, Finance, and Software industries. Gregg holds an MBA in Management from Saint Joseph’s University’s Haub School of Business and a BS in Business Administration from Rider University. Gregg has a passion for data, systems, & business processes and strives to work towards solutions that benefit all.
Ajay Gupta

Vice President, Cyberdefense, Data and Threat Management

Cencora, Inc.
- Cybersecurity Concerns Within the Pharmaceutical Industry
  Wednesday, March 15, 2023 | 9:00—10:15 AM
  
  JW Grand Ballroom 5 & 6
Ajay Gupta

Vice President, Cyberdefense, Data and Threat Management

Cencora, Inc.
- Cybersecurity Concerns Within the Pharmaceutical Industry
  Wednesday, March 15, 2023 | 9:00—10:15 AM
  
  JW Grand Ballroom 5 & 6
Cameron J. Hall

Chief Operating Officer

VineMeds, LLC
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Cameron J. Hall

Chief Operating Officer

VineMeds, LLC
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Bruce Harold

Director of EDI

KeySource
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 5 & 6
Bruce Harold

Director of EDI

KeySource
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 5 & 6
Bruce Harold has been the director of EDI and the technical lead and SME for DSCSA since January 2022. Previously he served in these roles for several years at The Harvard Drug Group. Bruce has been involved with DSCSA since the law was signed, though he had a break in 2020 and 2021—the quieter years in terms of new requirements. He has been an active participant in HDA's Traceability Implementation Work Group (TIWG) and HDA's Exceptions Handling Workgroup. He has led KeySource’s integration efforts with their solution provider and has been working directly with vendors and customers to identify and resolve EPCIS exceptions in both testing and production.
Jennifer K Harrison

Senior Portfolio Executive, Distribution

Apexus, LLC
- C3: Successful 340B Implementation
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 3 & 4
Jennifer K Harrison

Senior Portfolio Executive, Distribution

Apexus, LLC
- C3: Successful 340B Implementation
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 3 & 4
Cynthia Hetherington

President

Hetherington Group
- G3: Where to Look for Stolen Cargo Being Sold
- Cybersecurity Concerns Within the Pharmaceutical Industry
Cynthia Hetherington

President

Hetherington Group
- G3: Where to Look for Stolen Cargo Being Sold
- Cybersecurity Concerns Within the Pharmaceutical Industry
Cynthia Hetherington, MLS, MSM, CFE, CII is the founder and president of Hetherington Group, a consulting, publishing, and training firm that leads in due diligence, corporate intelligence, and cyber investigations by keeping pace with the latest security threats and assessments. She has authored three books on how to conduct investigations, is the publisher of the newsletter, Data2know: Internet and Online Intelligence, and has trained over 180,000 investigators, security professionals, attorneys, accountants, auditors, military intelligence professionals, and federal, state, and local agencies on best practices.

For more than 25 years, Ms. Hetherington has led national and international investigations in corporate due diligence and fraud, personal asset recovery, and background checks. With a specialization in the financial, pharmaceutical, and telecommunications industries, her investigations have recovered millions of dollars in high profile corruption cases, assisting on the investigations of the top two Ponzi cases in United States history.

Ms. Hetherington provides expert commentary for national and international media outlets, including, the New York Times, Wall Street Journal, Irish Times, Washington Times, ABC News, and VoiceAmerica. Ms. Hetherington has presented at over 500 conferences across North America. In 2012, the Association of Certified Fraud Examiners named her the James Baker Speaker of the Year.

In 2015, Ms. Hetherington founded the OSMOSIS Institute, host of the annual OSMOSIS Conference. Hundreds of investigators across the nation attend to gain insights into Open Source Intelligence and receive training from the most recognized social media and open source trainers in North America.
John Iannarelli

Speaker, Author, Consultant

FBI John, The Voice of Cyber and Security
- B4: Active Shooter Awareness and Preparedness
- C4: Leadership & Ethics Lessons from the FBI
John Iannarelli

Speaker, Author, Consultant

FBI John, The Voice of Cyber and Security
- B4: Active Shooter Awareness and Preparedness
- C4: Leadership & Ethics Lessons from the FBI
Daniel Jackson

Manager - EMPM - Serialization

Regeneron Healthcare Solutions
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Daniel Jackson

Manager - EMPM - Serialization

Regeneron Healthcare Solutions
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Connie Jung

Senior Advisor for Policy

U.S. Food and Drug Administration
- A1: FDA DSCSA Overview and Update
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Connie Jung

Senior Advisor for Policy

U.S. Food and Drug Administration
- A1: FDA DSCSA Overview and Update
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Dr. Jung is currently Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR) in FDA’s Center for Drug Evaluation and Research, Office of Compliance. Her work focuses on development of policy and regulatory strategies to improve the security and integrity of the U.S. drug supply to protect patients from counterfeit or stolen product. She received her B.S. in Pharmacy from The Ohio State University and her Ph. D. in Pharmaceutical Sciences from the University of Cincinnati. Dr. Jung joined the FDA in 1999 as a toxicology researcher in the Center for Food Safety and Applied Nutrition, and later served as a Regulatory Reviewer of bioequivalence studies in the Office of Generic Drug before working on supply chain issues.
Georg Jürgens

Manager Industry Solutions & OCI Co-Chair

Spherity, Inc.
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Georg Jürgens

Manager Industry Solutions & OCI Co-Chair

Spherity, Inc.
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
After graduating in Business Administration from Technical University of Munich, Georg worked as manager for a large German retailer and as product owner for a software house for supply chain management services. Joining Spherity as first employee in 2018, he is today responsible for industry solutions built on top of the Spherity Cloud Identity Wallet. Currently, Georg is rolling out the Credentialing Service for authorized trading partners to enable compliance with the US Drug Supply Chain Security Act. He represents Spherity on OCI, HDA and PDG tasks forces for DSCSA.
Devray Kirkland

Chief Diversity, Equity and Inclusion Officer

Cardinal Health, Inc.
- F4: Introducing Diversity, Equity and Inclusion into Your Workplace
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 7 & 8
Devray Kirkland

Chief Diversity, Equity and Inclusion Officer

Cardinal Health, Inc.
- F4: Introducing Diversity, Equity and Inclusion into Your Workplace
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 7 & 8
Devray Kirkland is vice president, Diversity and Inclusion (D&I) and chief diversity officer (CDO) for Cardinal Health, a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.

As CDO, Devray has led the development and implementation of a comprehensive, enterprise-wide diversity strategy through related programs, initiatives, and projects. He also provides direction to business segments on tactical programs and systems related to attracting, retaining, and promoting a diverse workforce. In partnership with the Cardinal Health Executive Committee and Diversity & Inclusion Council, Devray fosters critical dialogue and strategic counsel across the business to progress and sustain an inclusive work culture. He was integral in the formation of both the D&I Council and employee resource groups at Cardinal Health.

Devray joined Cardinal Health in 2012 as Director, Talent Management, for the company’s Medical segment. He also held the same position supporting the Pharmaceutical segment during his tenure.

Prior to joining Cardinal Health, Devray held numerous HR management and development roles with The Scotts Miracle-Gro company, L Brands (formerly Limited Brands), and Retail Ventures, Inc.

Rooted in community and servant leadership, Devray sits on the Board of Directors for the American Heart Association of Central Ohio and the Board of Trustees for the Mount Carmel College of Nursing. He is a long-serving member of the Alpha Phi Alpha Fraternity. He has also volunteered his time as a youth football coach in Westerville, Ohio, and for Dublin Scioto High School.
Devray holds a master’s degree in Human Resource Development from Bowie State University in Bowie, Maryland, and bachelor’s degree in Zoology Management from
Howard University in Washington, D.C. Additionally, he holds multiple certifications for both HR and D&I.

He resides in Westerville, Ohio, with his wife, Nicky, and their son, Devray II. Devray is a sports fan, loves traveling, working with the youth community, and most of all – spending time with his family.
Abigail Kizer

Associate Director, HDA PAC and Grassroots

Healthcare Distribution Alliance
- G2: Telling the Industry Value Story: Grassroots and Communications Engagement with HDA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 1 & 2
Abigail Kizer

Associate Director, HDA PAC and Grassroots

Healthcare Distribution Alliance
- G2: Telling the Industry Value Story: Grassroots and Communications Engagement with HDA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 1 & 2
Leah D. Lindahl

Vice President, State Government Affairs

Healthcare Distribution Alliance
- C2: State of the States
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 1 & 2
Leah D. Lindahl

Vice President, State Government Affairs

Healthcare Distribution Alliance
- C2: State of the States
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 1 & 2
Leah Lindahl is Vice President of State Government Affairs for HDA. In this role, Lindahl provides leadership and oversight for HDA’s state legislative and regulatory activities, advocating for sound public policy that supports patient access to medicines and medical products through safe, efficient and effective distribution. Previously, she covered a 19-state region across the western U.S., most recently as Senior Director of State Government Affairs.

Prior to joining HDA in 2016, Lindahl was the Vice President of the Colorado BioScience Association (CBSA). In this role, Lindahl ensured the bioscience industry was represented to its fullest potential by managing the association’s strategic planning and implementation of public policy initiatives on the state and federal level, sponsorship retention and expansion, program planning and overall membership development activities. Before joining CBSA, Lindahl was an account executive with The Kenney Group, a regional political consulting firm, where she managed healthcare, patient advocacy and the life science industry.

Lindahl earned a bachelor's degree in Journalism and Political Science from Colorado State University.
Craig Little

Senior Systems Developer

Value Drug Company
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Craig Little

Senior Systems Developer

Value Drug Company
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Craig Little is a Senior Systems Developer for Value Drug where he has been a part of Value Drug’s DSCA efforts for the past 8 years. Currently his role puts him in a lead position for all fecets of Value Drug’s DSCSA implementation across the organization, which includes efforts from Vendor and Dispenser onboarding through technical specification review and integration with their ERP, Warehouse Management, and Third Party Systems.

He has over 30 years experience in system development and integration in the Healthcare and Pharmaceutical fields ranging from Physician Management Sytems, Home Nursing Clinical and Billing Systems, Hospital Billing Systems and now, Wholesale Pharmaceutical distribution systems.
Erik A. Little

SVP, Replenishment Operations

Cencora, Inc.
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 3 & 4
Erik A. Little

SVP, Replenishment Operations

Cencora, Inc.
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 3 & 4
Danielle Lobo

Marketing Manager

Blue Link ERP
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Danielle Lobo

Marketing Manager

Blue Link ERP
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Douglas M. Long

Vice President, Industry Relations

IQVIA
- U.S. Pharmaceutical Market and Innovation – What’s In, What’s Out, What’s Ahead
  Tuesday, March 14, 2023 | 3:15—4:15 PM
  
  JW Grand Ballroom 5 & 6
Douglas M. Long

Vice President, Industry Relations

IQVIA
- U.S. Pharmaceutical Market and Innovation – What’s In, What’s Out, What’s Ahead
  Tuesday, March 14, 2023 | 3:15—4:15 PM
  
  JW Grand Ballroom 5 & 6
Doug Long’s dedication and leadership in healthcare spans four decades. Doug has unparalleled experience and perspective on pharmaceutical distribution and the changing U.S. and global healthcare marketplace.

As Vice President of Industry Relations for IQVIA (formerly QuintilesIMS) – the world’s largest pharmaceutical information company – Doug has been a leader with the company since 1989 in implementing health databases, developing new products and fostering relationships with distributors, manufacturers, retailers and industry associations.

Doug’s annual Industry Year in Review showcases his unique perspective on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends and biotechnology.

Wholesalers, retailers, manufacturers and healthcare trade associations rely on him for guidance, direction and industry expertise. Doug is a highly sought-after industry speaker at healthcare association and trade meetings. He also serves as a permanent member of the Editorial Advisory Board of HealthCare Distributor magazine.

Doug is the recipient of several industry achievement awards –the IFPW (International Federation of Pharmaceutical Wholesalers) Leadership award (2016), the Harold W. Pratt Award, bestowed by the National Association of Chain Drug Stores (2012); the Nexus Award for Lifetime Achievement by the Healthcare Distribution Management Association (2004); and, IMS Health’s prestigious Summit Award (2003) and the Chinese Association of Pharmaceutical Commerce 2017 Award for his contributions to the Chinese Supply Chain.

Prior to IQVIA, Doug was at Nielsen Market Research for 16 years in sales and marketing capacities. A native of Illinois, Doug received a BA from DePauw University and an MBA from Fairleigh Dickinson University.
Nicolette Louissaint

Senior Vice President, Policy and Strategic Planning

Healthcare Distribution Alliance
- A2: ESG in the Healthcare Distribution Industry
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
Nicolette Louissaint

Senior Vice President, Policy and Strategic Planning

Healthcare Distribution Alliance
- A2: ESG in the Healthcare Distribution Industry
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
Dr. Nicolette Louissaint serves as the Senior Vice President for Policy and Strategic Planning for the Healthcare Distribution Alliance (HDA). In this role, she leads HDA’s efforts to build policies and strategic approaches to bolster supply chain resilience and reinforce the role of healthcare distributors in the healthcare ecosystem.

She previously served as the Executive Director and President of Healthcare Ready, a 501(c)(3) organization that focuses on strengthening the United States’ healthcare supply chain preparedness and response before, during and after natural disasters and disease pandemics. Under her leadership, Healthcare Ready strengthened its position as a facilitator and coordinator that improves our nation's ability to plan for and respond to threats that disrupt patient access to healthcare during crises, including COVID-19.

Prior to this, Dr. Louissaint served as the Senior Advisor to the U.S. Department of State’s Special Coordinator for Ebola during the height of the 2014 epidemic. In this role, she was responsible for coordinating international efforts and jumpstarted the diplomatic response to the epidemic. Earlier in her career, Nicolette served as a Foreign Affairs Officer in the U.S. Department of State’s Bureau of Economic and Business Affairs. As the lead officer for health intellectual property and trade issues, she developed on policies and strategies related to pharmaceutical counterfeiting, pharmaceutical trade, supply chain, climate change and other science and technology development issues.

Dr. Louissaint previously served on the Federal Emergency Management Agency’s National Advisory Council in 2019 and chaired the Equity Working Group. Her current roles also include serving on Baltimore City’s Sustainability Commission, as a board member of Project HOPE, and as a Co-Chair of theHealthcare and Public Health Sector Coordinating Council. In 2020, Dr. Louissaint was named one of The Root 100 Most Influential African Americans.

She earned her bachelor’s degrees in Chemical Engineering and Biological Sciences from Carnegie Mellon University, a PhD in Pharmacology and Molecular Sciences from Johns Hopkins University School of Medicine, and an MBA from the University of Baltimore. She completed post-doctoral fellowships at the Johns Hopkins University and the American Association for the Advancement of Science.
Julie Malone

Regulatory Affairs Manager

Value Drug Company
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Julie Malone

Regulatory Affairs Manager

Value Drug Company
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Julie Malone is the Regulatory Affairs Manager for Value Drug Company where she has been a part of the DSCSA team for the past seven years. In her role at VDC, she developed a regulatory affairs program across departments and additionally developed the DSCSA suspect and illegitimate product investigation system. A proven risk manager and ethical strategist, Julie has maintained VDC’s accreditation status through the NABP Drug Distributor program. With the ability to synthesize complex policy and high velocity issues Julie has contributed to compliant business operations and profitability. She has been an active member at HDA serving on several committees including the Technology Implementation Work Group. With over 20 years of experience in both the private and public sectors, she served on the budget and policy staff for former Florida Governor Jeb Bush, as well as an Executive Director for several state licensing boards within the Florida Department of Business and Professional Regulation. Julie holds a Master’s degree in Journalism from Regent University and a Bachelor of Science degree in Political Science from Carnegie Mellon University.
Megan Maltenfort

Vice President, ESG

Cardinal Health, Inc.
- A2: ESG in the Healthcare Distribution Industry
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Megan Maltenfort

Vice President, ESG

Cardinal Health, Inc.
- A2: ESG in the Healthcare Distribution Industry
  Monday, March 13, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Eric Marshall

Executive Director

Partnership for DSCSA Governance (PDG)
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Eric Marshall

Executive Director

Partnership for DSCSA Governance (PDG)
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- C1: DSCSA - November 27, 2023: Are We There Yet?
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 5 & 6
Mike’s responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain. He represents Pfizer externally on various customer engagements and industry interactions relative to channel security and works closely with internal Pfizer colleagues to implement approved strategies. Mike has been directly involved with Pfizer’s global projects to implement serialization and is responsible for ensuring compliance with the U.S. Drug Supply Chain Security Act (DSCSA) requirements. He also works closely with Pfizer’s Global Security organization as it relates to investigations of suspected counterfeit or adulterated Pfizer products and is a member of the GS1 Healthcare US. Mike has 22 years of operational experience within the pharmaceutical industry.
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 5 & 6
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 5 & 6
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability. Scott leads McKesson’s Traceability Team working on implementation across McKesson’s various business units.

Scott joined McKesson in 1987 and had previous roles in Finance, Distribution Center Management and as a Regional Vice President of Distribution Operations. Scott has participated in McKesson’s integration of acquisitions over the last 16 years.

Scott has been active in HDA’s Traceability Workgroup, the HDA Industry Relations Council and participates in several committees including the FGAC, RAC and SGAC. He is tri-chair of GS1 Global Healthcare Leadership Team and is a member of the GS1 US Healthcare Executive Leadership Committee.

Scott has a BA in Accountancy and a MBA from the University of Wisconsin – La Crosse.
Tracy Nasarenko

Vice President of Community Engagement, Healthcare

GS1 US
- B1: EPCIS Standards Overview and Perspectives
- G1: Traceability Roundtables
Tracy Nasarenko

Vice President of Community Engagement, Healthcare

GS1 US
- B1: EPCIS Standards Overview and Perspectives
- G1: Traceability Roundtables
Tracy Nasarenko, vice president of Community Engagement at GS1 US for Healthcare, is an accomplished leader with more than 20 years of experience in healthcare and pharmaceutical supply chain, finance, product management, marketing, and operations.

In her current role, Ms. Nasarenko leads a collaborative healthcare industry group focused on addressing supply chain challenges and meeting the requirements of regulations like the Drug Supply Chain Security Act (DSCSA). Using GS1 Standards, the most widely used supply chain standards in the world, Ms. Nasarenko guides the implementation of these standards to help the pharmaceutical industry deliver safe products to patients.

Prior to joining GS1 US, Ms. Nasarenko held several leadership positions with SPI Pharma Inc. Most recently, she served as a site general manager, overseeing end-to-end operations and performance of the entire team, where she built a culture of engagement, innovation, and collaboration.

Ms. Nasarenko earned her bachelor’s degree from Villanova University and received her Master of Business Administration from West Chester University.
Maryann Nelson

Regulatory Manager

Cardinal Health, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
- G1: Traceability Roundtables
Maryann Nelson

Regulatory Manager

Cardinal Health, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
- G1: Traceability Roundtables
Maryann Nelson is a Regulatory Manager with Cardinal Health, Inc. responsible for developing strategies to insure supply chain integrity, preventing prescription drug diversion and complying with state and federal legislative requirements. She has over 30 years of experience in Pharmaceutical Distribution. She is actively involved with industry organizations, including HDA and GS1, focused on implementing the Track and Trace requirements of the Drug Supply Chain Security Act (DSCSA).

Ms. Nelson is a graduate of The Pennsylvania State University where she received a BS degree in Business Logistics.
Anne M. Nevel

Vice President, Education

Healthcare Distribution Alliance
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Anne M. Nevel

Vice President, Education

Healthcare Distribution Alliance
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
As HDA’s Vice President, Education, Anne Nevel is responsible for the development and oversight of the strategy for industry education by developing content and supporting information-sharing for HDA’s conferences, seminars and other programming. Additionally, Anne manages the planning, organization and coordination of industry and internal DEI efforts, as well as staff professional development.

Prior to joining HDA in November 2016, Anne provided educational program oversight for various healthcare and trade associations, including the American Gastroenterological Association and the Helicopter Association International. She graduated from Florida State University with a degree in Criminology.
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Leon Nevers is the Director of Procurement and Business Development with H-E-B Pharmacy. Leon has been engaged in retail buying and selling for a lifetime. He actively works with suppliers, employers, state and U.S. political leaders, and a variety of health care providers to provide lifestyle changes that keep Texans healthy at H-E-B.

Leon has managed direct relationships with hundreds of H-E-B suppliers of Rx, OTC, and Home Diagnostics controlling an annual budget of over $2 billion per year. He currently is Chairman of The Buyers Consortium, LLC, representing 1200 retail stores and $1 billion in Generics Purchasing opportunity with group contracting. He directs, trains, and coaches business development experts to support all aspects of procurement, immunizations, store communications, third party reimbursement, specialty pharmacy, medication therapy management and helps form strategies for business development and buying.

With extensive experience in both the pharmacy and retail industries, Leon looks for simple solutions that can make life long health improvements in a value market. He believes in serving others as a formula for personal success.
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- F1: HDA Perspectives on FDA DSCSA Activities
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 5 & 6
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- F1: HDA Perspectives on FDA DSCSA Activities
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 5 & 6
Tish Eggleston Pahl is a principal at Olsson Frank Weeda Terman Matz PC. She is regulatory counsel to drug, cosmetic, dietary supplement and food clients with concerns before the Food and Drug Administration, the Federal Trade Commission, and other federal agencies. Her work has encompassed representation of companies making and marketing human and animal prescription and over-the-counter (OTC) drugs, dietary supplements, and cosmetics. She has particular expertise in the areas of health care communications, advertising and labeling of FDA-regulated products. Further, she advises trade association clients on a range of antitrust and trade regulation issues.

Since November 2013, Tish has been heavily involved with implementation of the Drug Quality and Security Act (DQSA). She has advised pharmacy compounders and outsourcing facilities on their new FDA responsibilities under Title I of the DQSA. She has worked closely with pharmaceutical supply chain stakeholders, including manufacturers, repackagers, and wholesale distributors, on implementation of Title II of the DQSA, the Drug Supply Chain Security Act (DSCSA).

Tish is a regular participant in HDA activities, providing FDA regulatory and antitrust counsel to the Public Policy Council, the Traceability Implementation Work Group, the Regulatory Affairs Committee, the Returns Task Force, and other committees.

Tish graduated from Northwestern University and earned her Juris Doctor from Northwestern University (cum laude).
John E. Parker

Senior Vice President, Communications and Marketing

Healthcare Distribution Alliance
- G2: Telling the Industry Value Story: Grassroots and Communications Engagement with HDA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 1 & 2
John E. Parker

Senior Vice President, Communications and Marketing

Healthcare Distribution Alliance
- G2: Telling the Industry Value Story: Grassroots and Communications Engagement with HDA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 1 & 2
John Parker is a seasoned strategic communications and marketing professional with broad leadership experience and progressive management and operational responsibilities. Throughout his career, he has represented sectors from across the healthcare spectrum, while working for major trade associations and a Fortune 20 company. John has worked extensively with national and trade media to advance major public health and wellness initiatives, shaped the debate on the most pressing policy issues facing the country, and navigated through periods of crisis resulting from legislative and legal scrutiny. Notably, for the past decade, John has played a central role in how his organizations responded to health reform, the opioid crisis and COVID-19.

John currently serves as the Senior Vice President of Communications and Marketing for the Healthcare Distribution Alliance (HDA), the national organization representing pharmaceutical distributors and the healthcare supply chain. Prior to joining HDA, John spent nearly a decade in communications leadership roles with the Blue Cross and Blue Shield Association and UnitedHealth Group. His work in the health insurance industry was preceded by a stint at the Association of American Medical Colleges, where he served as the primary spokesperson with the media on key issues in academic medicine and managed the association's external publications. John’s initial exposure to communications was as an editor and reporter for one of the leading publishers of trade newsletters following FDA and its regulation of the drug and device industries and NIH.

John serves on the Board of Directors of the Arlington Free Clinic, an organization in northern Virginia dedicated to providing healthcare services to uninsured and underinsured adults.

John graduated from the University of Wisconsin-Madison.
Julie Plake

Manager of Community Engagement – Immersive Learning

United Way of Central Indiana
- B5: In One Moment: Understanding Poverty from the Lens of Real Families
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 9 & 10
Julie Plake

Manager of Community Engagement – Immersive Learning

United Way of Central Indiana
- B5: In One Moment: Understanding Poverty from the Lens of Real Families
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 9 & 10
Thomas W. Prevoznik

Assistant Administrator, Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration (closed to the media)
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Thomas W. Prevoznik

Assistant Administrator, Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration (closed to the media)
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Acting Assistant Administrator (DAA) Thomas W. Prevoznik began his career with the Drug Enforcement Administration (DEA) in February 1991. Upon his graduation from Basic Diversion Investigator Training, DAA Prevoznik was assigned as a Diversion Investigator (DI) to the Philadelphia Field Division. After serving in many supervisory roles in the Philadelphia Field Division, New Jersey Field Division, and DEA Headquarters, in August 2019, he was promoted to the Senior Executive Service as DAA of the Diversion Control Division.

DAA Prevoznik is a graduate from the University of Notre Dame, with a Bachelor of Arts in 1987; and the University of Virginia, with a Masters in Adult Education in 2004.
Senthil S. Rajaratnam

Senior Director, Global Serialization and UDI

Lilly USA, LLC
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Senthil S. Rajaratnam

Senior Director, Global Serialization and UDI

Lilly USA, LLC
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Senthil Rajaratnam is the Director for Global Serialization and UDI implementation. In his role, Senthil leads the global strategy and implementation for serialization and product traceability for pharmaceutical products and Unique Device Identification implementation for medical devices. Senthil coordinates with the Lilly’s affiliate offices, packaging sites, engineering and IT teams to implement the right solutions to ensure compliance with serialization/UDI marking and reporting requirements.

Senthil has been with Eli Lilly and Company for 20 years. Senthil’s key expertise includes packaging line equipment and systems, warehousing, distribution and logistics area of the supply chain and has deep knowledge in the business processes and solutions in this space. He is also the subject matter expert on GS1 standards and is part of various industry workgroups that work towards a common goal of providing advocacy to influence the adoption of global standards, harmonizing requirements and help governments achieve their goals leveraging serialization. He is currently on the Board of Directors for Partnership for DSCSA Governance (PDG) and also part of the Healthcare Leadership team of GS1 Healthcare Global organization.
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- E1: Moving Downstream: Perspectives from the Dispenser Community on Data-Flow Endpoints
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 5 & 6
Michael Rowe

Director, DSCSA/Serialization Services

Two Labs Pharma Services
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Michael Rowe

Director, DSCSA/Serialization Services

Two Labs Pharma Services
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Matt Sample

SVP, Manufacturer and Replenishment Operations

Cencora, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 5 & 6
Matt Sample

SVP, Manufacturer and Replenishment Operations

Cencora, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 5 & 6
Matt Sample is the Vice President of Manufacturer Operations at AmerisourceBergen. He is responsible for the maintenance of vendor and item master data, driving the adoption of supply chain standards internally and with manufacturer trading partners, and leading the implementation of DSCSA across all AmerisourceBergen business units. In addition to the core drug distribution business responsibilities, Matt is responsible for the DSCSA serialization efforts within their pharmaceutical manufacturing and repackaging businesses and leads our Covid19 Therapies operations efforts with the United States Government.

He has over 17 years of experience in the medical device, pharmaceutical and life sciences industry, working both for manufacturers, wholesalers and for a large consulting firm. He has held various roles in the areas of product development, lean six sigma, business system implementation and operational leadership. Prior to joining AmerisourceBergen, Matt was the serialization program lead at a mid-size pharmaceutical company, and the UDI program manager a large medical device manufacturer.
Farah M. Simonett

Vice President, Communications and Marketing

Healthcare Distribution Alliance
- G2: Telling the Industry Value Story: Grassroots and Communications Engagement with HDA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 1 & 2
Farah M. Simonett

Vice President, Communications and Marketing

Healthcare Distribution Alliance
- G2: Telling the Industry Value Story: Grassroots and Communications Engagement with HDA
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 1 & 2
Farah Simonett is a communications, marketing and creative services professional with more than 15 years of progressive experience in not-for-profit healthcare and membership organizations.

As the Healthcare Distribution Alliance’s (HDA) Vice President of Communications and Marketing, Farah serves as primary content strategist, executive speechwriter, media spokesperson and editor-in-chief for the national association representing healthcare distributors. HDA members are the vital link between 1,400 manufacturers and nearly 330,000 providers, delivering more than 11 million medicines and healthcare products safely and reliably each day.

Since joining HDA in 2008, Farah has led numerous communications and marketing programs across the association, including the rebranding of HDA, the launch of the organization’s award-winning Health Delivered campaign and Allied Against Opioid Abuse initiative. She is a trusted advisor with the proven ability to lead teams under pressure, on deadline and through crisis.

Farah is passionate about communicating to audiences across a range of mediums.Most recently, she has directed efforts to spotlight the distribution industry’s value proposition through enhanced storytelling and member engagement. Over the past few years, she has covered HDA members' response to the COVID-19 crisis as well as launched the association’s Faces of the Supply Chain video series. Further, she created (and now spearheads) HDA’s internal communications program.

Farah’s first exposure to the healthcare industry was through working in HIV/AIDS-related clinical trials at Georgetown University Medical Center in Washington, D.C. She graduated from The College and William and Mary in Virginia.
Sean Spears

Senior Director, Trade and Pharmacy Relations

Eisai, Inc.
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Sean Spears

Senior Director, Trade and Pharmacy Relations

Eisai, Inc.
- D4: Emerging Leaders Session: Crafting Your Career Path
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 7 & 8
Sean Spears serves as the Senior Director of Trade and Pharmacy Relations. In this role, Mr. Spears is responsible for business to business interactions with Eisai’s Direct Wholesale and Specialty Distributors along with downstream retail pharmacies and chains.

Mr. Spears is responsible for executing fee for service agreements for all direct Eisai customers. In addition, Sean is responsible for overseeing returns management, third party logistics, and data aggregation. He collaborates closely within Eisai that include Regulatory, Legal, Marketing, Sales, Finance and Compliance to build programs that help patients and pharmacists with compliance and persistency programs. His team also is responsible to launch Eisai products into the supply chain.

Mr. Spears has served as Co-Chairman for the Center for Healthcare Supply Chain Research and is active on customer advisory boards for Amerisource Bergen and H.D. Smith. He is also serving on HDMA’s Industry Relations Council.

Prior to joining Eisai in 2005, Mr. Spears had a long and successful career, starting in 1981, with Bertek Pharmaceuticals. He began his career as sales representative in Indiana and held many management positions including Regional Sales Manager, Hospital Sales Director, and Executive Director, Payor Markets.

Mr. Spears holds a Bachelor of Science degree from Hanover College, and has completed the Eisai Leadership University at Wharton School of Business.
Derron R. Stark

Partner, Transaction Strategy & Execution, Supply Chain, Health Sciences & Wellness

Ernst & Young LLP
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 3 & 4
Derron R. Stark

Partner, Transaction Strategy & Execution, Supply Chain, Health Sciences & Wellness

Ernst & Young LLP
- E3: COVID-19 After-Action: Have We Learned Lessons to Prepare for Future Events?
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 3 & 4
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
Tim Stearns is a Senior E-Commerce Analyst with Baxter HealthCare, focusing primarily on the distributor customer base. With over 22 years of experience in information systems, he has integrated back–end systems and implemented numerous EDI transaction sets focused on contract/chargeback administration, customer credit and invoicing, returns processing, order management and shipping notices, track–and–trace /pedigree systems design, customer–to–HIN alignment with HIBCC and distributor Fee for Service/inventory management agreements. Tim has served twice as co–chair of the HDMA Business Technology Committee, member of the HDMA eCommerce Task Force, member of the CSOS Working Group and the Health Industry Business Communications Council E-Business Council.
Matthew Strait

Deputy Assistant Administrator

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration (closed to the media)
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Matthew Strait

Deputy Assistant Administrator

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration (closed to the media)
  Tuesday, March 14, 2023 | 10:00—11:00 AM
  
  JW Grand Ballroom 1 & 2
Mr. Matthew J. Strait is a 20 year veteran of the Drug Enforcement Administration (DEA). His contributions to the DEA spans several regulatory roles specifically relating to entities authorized to possess controlled substances, currently surpassing 1.85 million nationwide. These roles include such activities as: importation, exportation, manufacture, distribution, prescribing, and dispensing.

Since 2017, Mr. Strait serves as chief policy advisor for the Diversion Control Division. He is the senior advisor to the Assistant Administrator on a broad range of policy issues impacting the DEA’s vast registrant population.

From 2015 - 2017, Mr. Strait directed day-to-day operations of DEA’s Congressional Affairs Section. The section responsible for assistance to the United States Congress on comprehensive legislation action. From 2009 to 2015, Mr. Strait served in the Congressional Affairs Section as a liaison where he worked to address important policy goals, including: drug disposal, synthetic drugs, anabolic steroids, quotas, and access to controlled substances by emergency medical professionals.

From 2004 - 2009, Mr. Strait served as the Unit Chief of DEA’s Quota and UN Reporting Unit. The unit responsible for oversight and adjudication of quota applications filed by DEA-registered manufacturers of schedule I and II controlled substances. Prior to 2004, Mr. Strait served as a Drug Science Specialist in the DEA’s Drug and Chemical Evaluation Section. This section began his DEA career in 1999 and where he fulfilled many of DEA’s reporting obligations pursuant to various United Nations’ treaties.

Mr. Strait graduated from the Virginia Polytechnic Institute and State University, Virginia Tech with both a Bachelor (’95) and Master of Science (’97) degrees.
Anil Suresh

Product Manager, DSCSA Expert

SAP
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Anil Suresh

Product Manager, DSCSA Expert

SAP
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Ann Marie Suter

Crime Prevention & First Aid Training

Code Red Solutions, LLC
- C5: Tales of the Unexpected and Avoiding the Attack
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 9 & 10
Ann Marie Suter

Crime Prevention & First Aid Training

Code Red Solutions, LLC
- C5: Tales of the Unexpected and Avoiding the Attack
  Monday, March 13, 2023 | 2:15—3:15 PM
  
  JW Grand Ballroom 9 & 10
Ann Marie Suter is a certified crime prevention coach. When it comes to close calls related to being a victim, Ann Marie may hold the world record if there was one. At a very young age Ann Marie could recognize when something was “off” in a situation. She would acknowledge the signs and signals and escape the danger.

After hearing of a brutal attack in a nearby community, Ann Marie decided it was time to share her experiences and strategies with others. Teaching others how to make prudent decisions, avoid crime and deescalate potentially dangerous situations is her personal mission. You may not be born recognizing and listening to your intuition but you can develop and sharpen it at any time.

Ann Marie is the lead instructor of her company Code Red Solutions, LLC. She advocates for all people to take charge and become their own first line of defense. She lives in a western suburb of Chicago with her husband Brad, four children and her German Shepherd.
Stephanie Trunk

Partner

ArentFox Schiff LLP
- D2: Overview of the Rapidly Shifting Reimbursement Policy Landscape
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 1 & 2
Stephanie Trunk

Partner

ArentFox Schiff LLP
- D2: Overview of the Rapidly Shifting Reimbursement Policy Landscape
  Monday, March 13, 2023 | 3:30—4:30 PM
  
  JW Grand Ballroom 1 & 2
Stephanie Trunk is a partner in the Health Law Group at Arent Fox LLP in Washington, D.C. Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers on regulatory, reimbursement and compliance matters. Her practice extends to counseling on drug pricing and government price reporting, HIPAA and privacy matters, counseling on Medicare Part D, developing corporate compliance programs, representing clients in contract negotiations and providing transactional support to her clients.

Prior to joining Arent Fox LLP, Ms. Trunk was in-house counsel to a pharmacy benefit management company. Ms. Trunk is the author of numerous chapters in health law treatises including a chapter on Controlling Fraud, Waste and Abuse in the Medicare Part D Program in the ABA/BNA's Health Care Fraud and Abuse: Practical Perspectives.

She received a JD with Highest Honors from the George Washington University Law School in 2003. Ms. Trunk also has a graduate certificate in health management from the George Washington University School of Public Health (2003) and she received a BS in Accounting Summa Cum Laude from the University of Maryland in 1997.
Brian P. Waldman

Partner

ArentFox Schiff LLP
- F1: HDA Perspectives on FDA DSCSA Activities
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 5 & 6
Brian P. Waldman

Partner

ArentFox Schiff LLP
- F1: HDA Perspectives on FDA DSCSA Activities
  Tuesday, March 14, 2023 | 11:15—12:15 PM
  
  JW Grand Ballroom 5 & 6
Brian Waldman concentrates his practice in the area of food and drug law and advertising law, counseling clients primarily on pharmaceutical, medical device, food, dietary supplement and cosmetic issues, with particular emphasis on developing effective strategies for introducing and distributing new products. Brian advises clients on a broad range of legal and regulatory issues in all phases of a product’s life cycle, including (i) developing appropriate strategies for the introduction of new ingredients and finished products, (ii) coordinating pre-market safety, efficacy, and claims evaluations, (iii) preparing FDA-related applications and notifications, (iv) designing compliant and effective labeling, advertising, and promotional materials, as well as educational materials, (v) ensuring post-marketing regulatory compliance, including compliance with adverse event reporting requirements and limitations on off-label promotion, and (vi) responding to threatened enforcement action. Brian has been advising clients including HDA on drug distribution issues since 1995.
Elizabeth Waldorf

Director, Global Traceability and Standards

TraceLink Inc.
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Elizabeth Waldorf

Director, Global Traceability and Standards

TraceLink Inc.
- B1: EPCIS Standards Overview and Perspectives
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 5 & 6
Elizabeth Waldorf is Director of Global Traceability and Standards at TraceLink. She is responsible for transforming global regulatory serialization and traceability regulations into product requirements for TraceLink’s portfolio of track and trace solutions. Elizabeth is a key contributor to TraceLink’s delivery of US, Brazil, China, South Korea, EU, Russia, India, Bahrain, Indonesia, Uzbekistan, and Kazakhstan government compliance modules. Elizabeth is focused on transforming country regulations into standardized models for traceability implementations.

Starting before the US DSCSA regulation was passed, Elizabeth has been driving pharmaceutical compliance at the state level. Her effort has continued through the passing of the US DSCSA regulation to the present day. A believer in achieving interoperability and operational efficiency through standards, Elizabeth’s editorial contributions include the following guidelines: “GS1 US Implementation Guideline for Applying GS1 Standards for DSCSA and Traceability (release 1.2)”, “GS1 US Implementation Guideline for the GS1 Lightweight Messaging Standard for Verification of Product Identifiers (releases 1.0, 1.1 and 1.2)”, and “GS1 US Applying GS1 System of Standards to Pharmaceutical Chain of Custody (releases 1.0 and 1.1)”. With a vigilant eye towards accelerating onboarding of trading partners for DSCSA message exchanges using EPCIS, Elizabeth collaborated to develop the GS1 US Rx EPCIS Conformance Testing Program. Committed to industry pharmaceutical compliance readiness, she is working towards the development of future releases of implementation guidelines to reflect evolved requirements and learnings.

With a passion for thought leadership, Elizabeth joined the GS1 US Healthcare Executive Leadership team and has taken on various leadership roles spanning GS1 US and GS1 Global. She currently co-chairs the GS1 US Rx Secure Supply Chain workgroup and GS1 EPICS/CBV 2.0 MWSG. As a member of GS1 Architecture team, Elizabeth serves as the GS1 Architecture liaison to GS1 Mission Specific Workgroups for EPICS/CBV 2.0, Pharmaceutical Clinical Trial Processes and Biological Samples. Elizabeth previously co-chaired the GS1 Brazil Traceability, Global Traceability Standard, and the GS1 Lightweight Messaging Standard workgroups.

Elizabeth is also an active leader in other industry and standards organizations including Partnership for DSCSA Governance (PDG), Healthcare Distribution Alliance (HDA) and serves as tri-chair of the Open Credentialing Initiative (OCI)’s Policy and Architecture team. She brings together her multi-discipline experience to advance and accelerate the delivery of specifications and adoption of interoperable standards. Before joining TraceLink, Elizabeth led Amgen’s global serialization and traceability initiatives, and drove adoption of GS1 standards across the company. In her 20-year tenure at Amgen, Elizabeth held numerous senior leadership roles managing cross functional teams in Global Supply Chain, Sales & Marketing, Enterprise Architecture, and Finance. Her leadership style and operational excellence mindset combined with business and information systems background have resulted in many successful implementations of process re-engineering and automation initiatives.
Andrew L. Wilson

Vice President, 340B Solutions

McKesson Corporation
- B3: 340B Update
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 3 & 4
Andrew L. Wilson

Vice President, 340B Solutions

McKesson Corporation
- B3: 340B Update
  Monday, March 13, 2023 | 11:30—12:30 PM
  
  JW Grand Ballroom 3 & 4
Andrew Wilson is Vice President for 340B Solutions with McKesson. He is responsible for guiding and coordinating McKesson 340B strategy and business oversight.

Andy has over 25 years of healthcare operations experience as a pharmacy leader in academic medical centers and integrated health systems. He has extensive 340B experience and has served as a member of the Executive Committee of the Safety Net Hospitals for Pharmaceutical Access (now 340B Health) and as Chair of the Hospital Advisory Board of the 340B Prime Vendor Program (Apexus).

Andy is the author of over 60 articles, book chapters and editorials in the medical and pharmacy literature including Financial Management for Health–System Pharmacists (2008). He has spent the past ten years leading consulting teams providing pharmacy management, operations and financial advisory services with a focus on 340B.
John Wirthlin

Principal Owner

Zebra Technologies
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
John Wirthlin

Principal Owner

Zebra Technologies
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
John Wirthlin is the Industry Principal for the Manufacturing, Transportation and Logistics markets where he is responsible for providing forward thinking, strategic oriented, technology recommendations to our clients and partners. John Wirthlin has 30 years of experience in healthcare, logistics, manufacturing, and information technology where he has led multiple strategic initiatives. John Wirthlin is viewed as a trusted advisor to his clients and organizations in which he has served.
Herbert Wong

Chief Customer Officer

Antares Vision Group
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6
Herbert Wong

Chief Customer Officer

Antares Vision Group
- G1: Traceability Roundtables
  Tuesday, March 14, 2023 | 2:00—3:00 PM
  
  JW Grand Ballroom 5 & 6

Registration and Hotel Information

Genesis Argueta
Sponsorship Opportunities

Lisa Kanfer
Exhibit Opportunities

Michelle Leslie
Membership

Lisa Gallagher
Conference Schedule, Speaker Information, and Education Content

Subrina Ghorashi

We use cookies, pixels and other technology to understand our users better and ensure that we give you the best experience on our website.

2023 Distribution Management Conference and Expo

March 12-15, 2023 | JW Marriott Indianapolis

2023 Distribution Management Conference and Expo

March 12-15, 2023 | JW Marriott Indianapolis

Speakers

Natalie Adams

Natalie Adams

Steven A. Adams

Steven A. Adams

Chris J. Anderson

Chris J. Anderson

Christopher Antypas

Christopher Antypas

Maurice Ashley

Maurice Ashley

Michael Benedick

Michael Benedick

Josh M. Bolin

Josh M. Bolin

Jon Brown

Jon Brown

Sean Edward Brzozowski

Sean Edward Brzozowski

Daniel Burke

Daniel Burke

Ian Cannell

Ian Cannell

Robert Celeste

Robert Celeste

Christopher Clement

Christopher Clement

Jason D. Cochran

Jason D. Cochran

Moogega Cooper

Moogega Cooper

Kelly Copes-Anderson

Kelly Copes-Anderson

Scott Cornwell

Scott Cornwell

Jesse Cortez

Jesse Cortez

Larry P. Cote

Larry P. Cote

Tom Cotter

Tom Cotter

Chester "Chip" Davis, Jr.

Chester "Chip" Davis, Jr.

Jeffery W. Denton

Jeffery W. Denton

Anita T. Ducca

Anita T. Ducca

Heather Easterling

Heather Easterling

Charles H. Forsaith

Charles H. Forsaith

Kristen L. Freitas

Kristen L. Freitas

Elizabeth A. Gallenagh

Elizabeth A. Gallenagh

John A. Gilbert

John A. Gilbert

Gregg A. Gorniak

Gregg A. Gorniak

Ajay Gupta

Ajay Gupta

Cameron J. Hall

Cameron J. Hall

Bruce Harold

Bruce Harold

Jennifer K Harrison

Jennifer K Harrison

Cynthia Hetherington

Cynthia Hetherington

John Iannarelli

John Iannarelli

Daniel Jackson

Daniel Jackson

Connie Jung

Connie Jung